Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Adenosine and Adenosine Receptors in the Immunopathogenesis and Treatment of Cancer Publisher Pubmed



Kazemi MH1, 2 ; Raoofi Mohseni S3 ; Hojjatfarsangi M4, 5 ; Anvari E6 ; Ghalamfarsa G7 ; Mohammadi H2, 8 ; Jadidiniaragh F2, 3, 8, 9
Authors
Show Affiliations
Authors Affiliations
  1. 1. Student Research Committee, Department of Immunology, School of Medicine, Iran University of Medical Sciences (IUMS), Tehran, Iran
  2. 2. Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
  3. 3. Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
  4. 4. Department of Oncology-Pathology, Immune and Gene Therapy Lab, Cancer Center Karolinska (CCK), Karolinska University Hospital Solna and Karolinska Institute, Stockholm, Sweden
  5. 5. Department of Immunology, School of Medicine, Bushehr University of Medical Sciences, Bushehr, Iran
  6. 6. Faculty of Medicine, Department of Physiology, Ilam University of Medical Sciences, Ilam, Iran
  7. 7. Medicinal Plants Research Center, Yasuj University of Medical Sciences, Yasuj, Iran
  8. 8. Faculty of Medicine, Department of Immunology, Tabriz University of Medical Sciences, Tabriz, Iran
  9. 9. Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

Source: Journal of Cellular Physiology Published:2018


Abstract

Tumor cells overcome anti-tumor responses in part through immunosuppressive mechanisms. There are several immune modulatory mechanisms. Among them, adenosine is an important factor which is generated by both cancer and immune cells in tumor microenvironment to suppress anti-tumor responses. Two cell surface expressed molecules including CD73 and CD39 catalyze the generation of adenosine from adenosine triphosphate (ATP). The generation of adenosine can be enhanced under metabolic stress like tumor hypoxic conditions. Adenosine exerts its immune regulatory functions through four different adenosine receptors (ARs) including A1, A2A, A2B, and A3 which are expressed on various immune cells. Several studies have indicated the overexpression of adenosine generating enzymes and ARs in various cancers which was correlated with tumor progression. Since the signaling of ARs enhances tumor progression, their manipulation can be promising therapeutic approach in cancer therapy. Accordingly, several agonists and antagonists against ARs have been designed for cancer therapy. In this review, we will try to clarify the role of different ARs in the immunopathogenesis, as well as their role in the treatment of cancer. © 2017 Wiley Periodicals, Inc.
Related Docs
View other Related Docs
1. Adenosine Blockage in Tumor Microenvironment and Improvement of Cancer Immunotherapy, Immune Network (2019)
2. Downregulation of A2ar by Sirna Loaded Peg-Chitosan-Lactate Nanoparticles Restores the T Cell Mediated Anti-Tumor Responses Through Blockage of Pka/Creb Signaling Pathway, International Journal of Biological Macromolecules (2019)
3. Cd73 Specific Sirna Loaded Chitosan Lactate Nanoparticles Potentiate the Antitumor Effect of a Dendritic Cell Vaccine in 4T1 Breast Cancer Bearing Mice, Journal of Controlled Release (2017)
4. Anti-Angiogenic Effects of Cd73-Specific Sirna-Loaded Nanoparticles in Breast Cancer-Bearing Mice, Journal of Cellular Physiology (2018)
5. Increased Efficacy of a Dendritic Cell–Based Therapeutic Cancer Vaccine With Adenosine Receptor Antagonist and Cd73 Inhibitor, Tumor Biology (2017)
6. Concomitant Blockade of A2ar and Ctla-4 by Sirna-Loaded Polyethylene Glycol-Chitosan-Alginate Nanoparticles Synergistically Enhances Antitumor T-Cell Responses, Journal of Cellular Physiology (2020)
7. The Role of Adenosine and Adenosine Receptors in the Immunopathogenesis of Multiple Sclerosis, Inflammation Research (2016)
8. Silencing of Hif-1Α/Cd73 Axis by Sirna-Loaded Tat-Chitosan-Spion Nanoparticles Robustly Blocks Cancer Cell Progression, European Journal of Pharmacology (2020)
Experts (# of related papers)
View all Related Experts
Fatemeh Atyabi (19)
Jamshid Hadjati (10)
Other Related Docs
9. Silencing of Il-6 and Stat3 by Sirna Loaded Hyaluronate-N,N,N-Trimethyl Chitosan Nanoparticles Potently Reduces Cancer Cell Progression, International Journal of Biological Macromolecules (2020)
10. Increased Susceptibility to Doxorubicin-Induced Cell Death in Acute Lymphocytic Leukemia Cells by Inhibiting Serine/Threonine Wee1 Kinase Expression Using the Chitosan-Carboxymethyl Dextran-Polyethylene Glycol-Tat Nanoparticles, Journal of Drug Delivery Science and Technology (2022)
11. Evaluation of Rip1k and Rip3k Expressions in the Malignant and Benign Breast Tumors, Tumor Biology (2016)
12. Regulatory T Cells in Breast Cancer As a Potent Anti-Cancer Therapeutic Target, International Immunopharmacology (2020)
13. Nanomedicine for Improvement of Dendritic Cell-Based Cancer Immunotherapy, International Immunopharmacology (2020)
14. Combined Inhibition of Cd73 and Zeb1 by Arg-Gly-Asp (Rgd)-Targeted Nanoparticles Inhibits Tumor Growth, Colloids and Surfaces B: Biointerfaces (2021)
15. Genetic and Pharmacological Targeting of A2a Receptor Improves Function of Anti-Mesothelin Car T Cells, Journal of Experimental and Clinical Cancer Research (2020)
16. Gene-Knocked Out Chimeric Antigen Receptor (Car) T Cells: Tuning up for the Next Generation Cancer Immunotherapy, Cancer Letters (2018)
17. Coinhibition of S1pr1 and Gp130 by Sirna-Loaded Alginate-Conjugated Trimethyl Chitosan Nanoparticles Robustly Blocks Development of Cancer Cells, Journal of Cellular Physiology (2020)
18. Downregulation of Cd73 in 4T1 Breast Cancer Cells Through Sirna-Loaded Chitosan-Lactate Nanoparticles, Tumor Biology (2016)
19. Targeting of Crosstalk Between Tumor and Tumor Microenvironment by Β-D Mannuronic Acid (M2000) in Murine Breast Cancer Model, Cancer Medicine (2017)
20. Solid Tumors Challenges and New Insights of Car T Cell Engineering, Stem Cell Reviews and Reports (2019)
21. Targeting Hypoxia and Hypoxia-Inducible Factor-1 in the Tumor Microenvironment for Optimal Cancer Immunotherapy, Journal of Cellular Physiology (2022)
22. Hypoxia Inducible Factors in the Tumor Microenvironment As Therapeutic Targets of Cancer Stem Cells, Life Sciences (2019)
23. The Immunobiology of Myeloid-Derived Suppressor Cells in Cancer, Tumor Biology (2016)
24. Silencing Adenosine A2a Receptor Enhances Dendritic Cell-Based Cancer Immunotherapy, Nanomedicine: Nanotechnology# Biology# and Medicine (2020)
25. A Randomized, Controlled, Phase Ii Clinical Trial of Β-D-Mannuronic Acid (M2000) in Pre-Surgical Breast Cancer Patients at Early Stage (T1-T2), Clinical and Experimental Pharmacology and Physiology (2019)
26. Blockade of Ctla-4 Increases Anti-Tumor Response Inducing Potential of Dendritic Cell Vaccine, Journal of Controlled Release (2020)
27. Mutation in Adora1 Identified As Likely Cause of Early-Onset Parkinsonism and Cognitive Dysfunction, Movement Disorders (2016)
28. Multiple Sclerosis: Therapeutic Applications of Advancing Drug Delivery Systems, Biomedicine and Pharmacotherapy (2017)
29. Application of Nanoparticle Technology in the Treatment of Systemic Lupus Erythematous, Biomedicine and Pharmacotherapy (2016)
30. Codelivery of Stat3 Sirna and Bv6 by Carboxymethyl Dextran Trimethyl Chitosan Nanoparticles Suppresses Cancer Cell Progression, International Journal of Pharmaceutics (2020)
31. Immune Regulatory Network in Successful Pregnancy and Reproductive Failures, Biomedicine and Pharmacotherapy (2017)
32. Ankylosing Spondylitis Monocyte-Derived Macrophages Express Increased Level of A2a Adenosine Receptor and Decreased Level of Ectonucleoside Triphosphate Diphosphohydrolase-1 (Cd39), A1 and A2b Adenosine Receptors, Clinical Rheumatology (2018)
33. Neurotransmission Systems in Parkinson's Disease, Reviews in the Neurosciences (2017)
34. The Roles of Metabolic Profiles and Intracellular Signaling Pathways of Tumor Microenvironment Cells in Angiogenesis of Solid Tumors, Cell Communication and Signaling (2022)
35. Pharmacological Targeting of Immune Checkpoint A2ar Improves Function of Anti-Cd19 Car T Cells in Vitro, Immunology Letters (2020)
36. Codelivery of Hif-1Α Sirna and Dinaciclib by Carboxylated Graphene Oxide-Trimethyl Chitosan-Hyaluronate Nanoparticles Significantly Suppresses Cancer Cell Progression, Pharmaceutical Research (2020)
37. Combination Cancer Immunotherapy With Dendritic Cell Vaccine and Nanoparticles Loaded With Interleukin-15 and Anti-Beta-Catenin Sirna Significantly Inhibits Cancer Growth and Induces Anti-Tumor Immune Response, Pharmaceutical Research (2022)
38. Silencing of P68 and Stat3 Synergistically Diminishes Cancer Progression, Life Sciences (2020)
39. Inhibition of Cd73 Using Folate Targeted Nanoparticles Carrying Anti-Cd73 Sirna Potentiates Anticancer Efficacy of Dinaciclib, Life Sciences (2020)
40. Herbal Extracts Induce Dermal Papilla Cell Proliferation of Human Hair Follicles, Annals of Dermatology (2015)
41. Advances in Therapeutic Targeting of Immune Checkpoints Receptors Within the Cd96-Tigit Axis: Clinical Implications and Future Perspectives, Expert Review of Clinical Immunology (2022)
42. Inhibition of Hif-1Α Enhances Anti-Tumor Effects of Dendritic Cell-Based Vaccination in a Mouse Model of Breast Cancer, Cancer Immunology# Immunotherapy (2016)
43. Immunotherapy a New Hope for Cancer Treatment: A Review, Pakistan Journal of Biological Sciences (2018)
44. Blockage of Immune Checkpoint Molecules Increases T-Cell Priming Potential of Dendritic Cell Vaccine, Immunology (2020)
45. Simultaneous Inhibition of Cd73 and Il-6 Molecules by Sirna-Loaded Nanoparticles Prevents the Growth and Spread of Cancer, Nanomedicine: Nanotechnology# Biology# and Medicine (2021)
46. Applications of Resveratrol in the Treatment of Gastrointestinal Cancer, Biomedicine and Pharmacotherapy (2022)
47. Inhibiting Hepatic Gluconeogenesis by Chitosan Lactate Nanoparticles Containing Crtc2 Sirna Targeted by Poly(Ethylene Glycol)-Glycyrrhetinic Acid, Drug Delivery and Translational Research (2019)
48. Nanoparticles and Targeted Drug Delivery in Cancer Therapy, Immunology Letters (2017)
49. The Skewed Balance Between Tregs and Th17 in Chronic Lymphocytic Leukemia, Future Oncology (2015)